High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study

(2015) Lene Sofie Granfeldt Østgård et al.   JOURNAL OF CLINICAL ONCOLOGY

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

(2010) S. Kayser et al.   BLOOD

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

(2009) M. R. Litzow et al.   BLOOD

Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia

(2009) Borje S Andersson et al.   CURRENT OPINION IN ONCOLOGY

Pediatric Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia

(2009) Dolly G. Aguilera et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS

(2008) Borje S. Andersson et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION